Literature DB >> 12427286

Interleukin-7 and immunorestoration in HIV: beyond the thymus.

Terry J Fry1, Crystal L Mackall.   

Abstract

One of the hallmarks of untreated HIV infection is a progressive loss of effective immunity to both HIV-associated and non-HIV antigens. Combination antiretroviral therapy can frequently control viral replication, resulting in variable levels of immune reconstitution, but has not resulted in restoration of effective immunity to the virus. Understanding the limitations of immune reconstitution following highly active antiretroviral therapy (HAART) and identifying approaches to enhance immunity in this context may not only improve outcome for patients with HIV infection but could also provide insight for immune reconstitution in other conditions associated with T cell depletion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427286     DOI: 10.1089/152581602760404603

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  7 in total

1.  IL-7 induces clathrin-mediated endocytosis of CD127 and subsequent degradation by the proteasome in primary human CD8 T cells.

Authors:  Elliott M Faller; Feras M Ghazawi; Marko Cavar; Paul A MacPherson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

Review 2.  From the raw bar to the bench: Bivalves as models for human health.

Authors:  José A Fernández Robledo; Raghavendra Yadavalli; Bassem Allam; Emmanuelle Pales Espinosa; Marco Gerdol; Samuele Greco; Rebecca J Stevick; Marta Gómez-Chiarri; Ying Zhang; Cynthia A Heil; Adrienne N Tracy; David Bishop-Bailey; Michael J Metzger
Journal:  Dev Comp Immunol       Date:  2018-11-29       Impact factor: 3.636

3.  Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells.

Authors:  Elizabeth Z Managlia; Alan Landay; Lena Al-Harthi
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS.

Authors:  Yuhuang Zheng; Huaying Zhou; Yan He; Zi Chen; Bo He; Mei He
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

5.  Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.

Authors:  Olivier Juffroy; Florence Bugault; Olivier Lambotte; Ivan Landires; Jean-Paul Viard; Loïc Niel; Arnaud Fontanet; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 6.  The Ban on US Government Funding Research Using Human Fetal Tissues: How Does This Fit with the NIH Mission to Advance Medical Science for the Benefit of the Citizenry?

Authors:  Joseph M McCune; Irving L Weissman
Journal:  Stem Cell Reports       Date:  2019-11-12       Impact factor: 7.765

7.  IL-7 receptor recovery on CD8 T-cells isolated from HIV+ patients is inhibited by the HIV Tat protein.

Authors:  Elliott M Faller; Mark J McVey; Paul A MacPherson
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.